THEMIS MEDICARE
|
THEMIS MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 61.83 | 79.22 | 38.86 | 26.97 | -11.70 |
| CEPS(Rs) | 73.23 | 89.52 | 37.85 | 26.28 | -5.49 |
| DPS(Rs) | 5.00 | 5.00 | 4.30 | 1.75 | - |
| Book NAV/Share(Rs) | 368.78 | 312.22 | 237.41 | 198.67 | 171.54 |
| Tax Rate(%) | 21.53 | 23.49 | 17.67 | 11.65 | 12.36 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 19.04 | 24.24 | 21.46 | 17.69 | 1.24 |
| EBIT Margin(%) | 23.17 | 26.36 | 19.32 | 15.30 | -1.66 |
| Pre Tax Margin(%) | 20.47 | 24.14 | 13.81 | 8.91 | -8.09 |
| PAT Margin (%) | 16.06 | 18.47 | 11.37 | 7.88 | -7.09 |
| Cash Profit Margin (%) | 19.02 | 20.87 | 15.08 | 11.98 | -2.74 |
| Performance Ratios | |||||
| ROA(%) | 11.78 | 17.93 | 7.32 | 4.86 | -4.29 |
| ROE(%) | 18.16 | 28.84 | 13.09 | 9.34 | -8.00 |
| ROCE(%) | 20.59 | 31.07 | 15.21 | 11.81 | -1.25 |
| Asset Turnover(x) | 0.73 | 0.97 | 0.64 | 0.62 | 0.60 |
| Sales/Fixed Asset(x) | 1.71 | 2.16 | 1.44 | 1.38 | 1.28 |
| Working Capital/Sales(x) | 2.83 | 3.77 | 4.04 | 7.85 | 57.83 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.58 | 0.46 | 0.69 | 0.73 | 0.78 |
| Receivable days | 126.49 | 82.40 | 142.49 | 158.78 | 140.57 |
| Inventory Days | 66.84 | 55.18 | 89.48 | 97.99 | 102.51 |
| Payable days | 130.58 | 87.30 | 163.89 | 227.30 | 203.52 |
| Valuation Parameters | |||||
| PER(x) | 18.87 | 11.78 | 7.21 | 8.90 | - |
| PCE(x) | 15.93 | 10.42 | 7.41 | 9.13 | -54.03 |
| Price/Book(x) | 3.16 | 2.99 | 1.18 | 1.21 | 1.73 |
| Yield(%) | 0.43 | 0.54 | 1.53 | 0.73 | - |
| EV/Net Sales(x) | 3.24 | 2.31 | 1.38 | 1.56 | 1.91 |
| EV/Core EBITDA(x) | 14.52 | 8.91 | 5.99 | 8.04 | 70.87 |
| EV/EBIT(x) | 13.97 | 8.75 | 7.14 | 10.20 | -115.15 |
| EV/CE(x) | 2.19 | 2.06 | 0.86 | 0.91 | 1.14 |
| M Cap / Sales | 3.03 | 2.18 | 1.12 | 1.09 | 1.48 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -10.21 | 71.07 | 14.43 | 9.71 | -12.29 |
| Core EBITDA Growth(%) | -22.73 | 92.37 | 35.77 | 690.93 | -82.35 |
| EBIT Growth(%) | -21.11 | 133.43 | 44.47 | 1,113.46 | -114.77 |
| PAT Growth(%) | -21.93 | 177.87 | 65.20 | 221.86 | -250.87 |
| EPS Growth(%) | -21.95 | 103.87 | 44.06 | 330.53 | -195.13 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.27 | 0.27 | 0.39 | 0.54 | 0.52 |
| Current Ratio(x) | 1.84 | 1.85 | 1.45 | 1.17 | 1.02 |
| Quick Ratio(x) | 1.38 | 1.35 | 0.99 | 0.84 | 0.67 |
| Interest Cover(x) | 8.58 | 11.86 | 3.51 | 2.40 | -0.26 |
| Total Debt/Mcap(x) | 0.09 | 0.09 | 0.33 | 0.45 | 0.30 |
Compare Financial Ratios of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹1,936.1 Cr | 0.9% | -5.8% | 51.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹364,831.0 Cr | -0.1% | -2.8% | 50.3% | Stock Analytics | |
| CIPLA | ₹113,471.0 Cr | 4.5% | -3.1% | 52.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,713.0 Cr | 4.6% | 1.4% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹101,960.0 Cr | 4.7% | 10.8% | 18.1% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,687.8 Cr | 3.1% | -4.1% | 80.4% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | 0.9% |
-5.8% |
51.4% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
